ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000259523.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.04120376	Resistant
ENSG00000259523.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.030699222	Resistant